{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:28:59Z","timestamp":1786987739997,"version":"build-2736575974"},"reference-count":94,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.drudis.2022.02.010","type":"journal-article","created":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T10:33:10Z","timestamp":1645266790000},"page":"1961-1973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics"],"prefix":"10.1016","volume":"27","author":[{"given":"Yuanhao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongren","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wukun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2022.02.010_b0005","doi-asserted-by":"crossref","first-page":"D443","DOI":"10.1093\/nar\/gkn656","article-title":"ARDB\u2014antibiotic resistance genes database","volume":"37","author":"Liu","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2022.02.010_b0010","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature17042","article-title":"Antibacterial drug discovery in the resistance era","volume":"529","author":"Brown","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2022.02.010_b0015","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1021\/acsnano.9b06814","article-title":"Engineering chirally blind protein pseudocapsids into antibacterial persisters","volume":"14","author":"Kepiro","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.drudis.2022.02.010_b0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00134-017-4962-2","article-title":"When antibiotic treatment fails","volume":"44","author":"Bassetti","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.drudis.2022.02.010_b0025","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1038\/s41467-019-12702-8","article-title":"Enantiomeric glycosylated cationic block co-beta-peptides eradicate Staphylococcus aureus biofilms and antibiotic-tolerant persisters","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2022.02.010_b0030","doi-asserted-by":"crossref","first-page":"1237435","DOI":"10.1126\/science.1237435","article-title":"The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria","volume":"342","author":"Deris","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.drudis.2022.02.010_b0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/bph.13895","article-title":"Drug repurposing screens and synergistic drug-combinations for infectious diseases","volume":"175","author":"Zheng","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.drudis.2022.02.010_b0040","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1021\/acsinfecdis.0c00890","article-title":"Recent innovations in bacterial infection detection and treatment","volume":"7","author":"Deusenbery","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.drudis.2022.02.010_b0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/jacs.5b11807","article-title":"The mechanism of action of lysobactin","volume":"138","author":"Lee","year":"2016","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2022.02.010_b0050","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.biomaterials.2013.10.053","article-title":"Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic beta-sheet forming peptide amphiphiles","volume":"35","author":"Ong","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2022.02.010_b0055","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/502S4a","article-title":"Drug development: a combined effort","volume":"502","author":"Maxmen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2022.02.010_b0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/antibiotics10030230","article-title":"Development of effective antibacterial treatment: lessons from the past and novel approaches","volume":"10","author":"Di Luca","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.drudis.2022.02.010_b0065","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3389\/fmicb.2018.01178","volume":"9","author":"Maslanova","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2022.02.010_b0070","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4161\/auto.24406","article-title":"Host and bacterial factors that regulate LC3 recruitment to Listeria monocytogenes during the early stages of macrophage infection","volume":"9","author":"Lam","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.drudis.2022.02.010_b0075","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.2174\/0929867326666191007163654","article-title":"Targeting bacterial antioxidant systems for antibiotics development","volume":"27","author":"Ren","year":"2020","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.drudis.2022.02.010_b0080","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tim.2016.12.008","article-title":"The role of reactive oxygen species in antibiotic-mediated killing of bacteria","volume":"25","author":"Van Acker","year":"2017","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.drudis.2022.02.010_b0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev-pharmtox-010814-124712","article-title":"Unraveling the physiological complexities of antibiotic lethality","volume":"55","author":"Dwyer","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.drudis.2022.02.010_b0090","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.ph.48.030186.003301","article-title":"Oxy-radicals and related species: their formation, lifetimes, and reactions","volume":"48","author":"Pryor","year":"1986","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.drudis.2022.02.010_b0095","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1002\/anie.202013366","article-title":"Bioorthogonal activation of dual catalytic and anti-cancer activities of organogold(I) complexes in living systems","volume":"60","author":"Long","year":"2021","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.drudis.2022.02.010_b0100","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1039\/C5CS00132C","article-title":"Chemical biology of anticancer gold(III) and gold(I) complexes","volume":"44","author":"Zou","year":"2015","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.drudis.2022.02.010_b0105","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/chem.201604512","article-title":"Gold(I) NHC complexes: antiproliferative activity, cellular uptake, inhibition of mammalian and bacterial thioredoxin reductases, and Gram-positive directed antibacterial effects","volume":"23","author":"Schmidt","year":"2017","journal-title":"Chemistry"},{"key":"10.1016\/j.drudis.2022.02.010_b0110","doi-asserted-by":"crossref","first-page":"19699","DOI":"10.3390\/molecules201119647","article-title":"Anticancer and antibacterial activity studies of Gold(I)-alkynyl chromones","volume":"20","author":"Hikisz","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2022.02.010_b0115","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1002\/chem.201103145","article-title":"Luminescent di- and polynuclear organometallic gold(I)-metal (Au2, {Au2Ag}n and {Au2Cu}n) compounds containing bidentate phosphanes as active antimicrobial agents","volume":"18","author":"Frik","year":"2012","journal-title":"Chemistry"},{"key":"10.1016\/j.drudis.2022.02.010_b0120","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0738-081X(91)90083-W","article-title":"Systemic gold therapy","volume":"9","author":"Papp","year":"1991","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.drudis.2022.02.010_b0125","series-title":"Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine","author":"Gielen","year":"2005"},{"key":"10.1016\/j.drudis.2022.02.010_b0130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0950-3579(05)80019-6","article-title":"Intramuscular versus oral gold therapy","volume":"4","author":"Kean","year":"1990","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.drudis.2022.02.010_b0135","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1021\/jm00281a001","article-title":"Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexes","volume":"15","author":"Sutton","year":"1972","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2022.02.010_b0140","doi-asserted-by":"crossref","first-page":"831","DOI":"10.18632\/oncotarget.5704","article-title":"Auranofin is a potent suppressor of osteosarcoma metastasis","volume":"7","author":"Topkas","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2022.02.010_b0145","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1039\/C7MT00311K","article-title":"Gold(i) phosphine compounds as parasite attenuating agents for malaria vaccine and drug development","volume":"10","author":"Ssemaganda","year":"2018","journal-title":"Metallomics"},{"key":"10.1016\/j.drudis.2022.02.010_b0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cbpa.2017.10.014","article-title":"Anticancer metal-N-heterocyclic carbene complexes of gold, platinum and palladium","volume":"43","author":"Zou","year":"2018","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.drudis.2022.02.010_b0155","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1039\/c1mt00062d","article-title":"Gold compounds as therapeutic agents for human diseases","volume":"3","author":"Berners-Price","year":"2011","journal-title":"Metallomics"},{"key":"10.1016\/j.drudis.2022.02.010_b0160","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/JB.00164-09","article-title":"Inhibition of selenium metabolism in the oral pathogen Treponema denticola","volume":"191","author":"Jackson-Rosario","year":"2009","journal-title":"J Bacteriol"},{"key":"10.1016\/j.drudis.2022.02.010_b0165","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/biomedicines9050504","article-title":"Strategies for the improvement of metal-based chemotherapeutic treatments","volume":"9","author":"Cirri","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2022.02.010_b0170","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/acs.jmedchem.9b01436","article-title":"Distorted gold(I)-phosphine complexes as antifungal agents","volume":"63","author":"Dennis","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2022.02.010_b0175","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10534-016-9921-9","article-title":"Gold(I) complex of 1,1\u2019-bis(diphenylphosphino) ferrocene-quinoline conjugate: a virostatic agent against HIV-1","volume":"29","author":"Gama","year":"2016","journal-title":"Biometals"},{"key":"10.1016\/j.drudis.2022.02.010_b0180","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jinorgbio.2011.05.011","article-title":"New bis(thiosemicarbazonate) gold(III) complexes inhibit HIV replication at cytostatic concentrations: potential for incorporation into virostatic cocktails","volume":"105","author":"Fonteh","year":"2011","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.drudis.2022.02.010_b0185","doi-asserted-by":"crossref","first-page":"e01947","DOI":"10.1128\/AAC.01947-16","article-title":"Phase I clinical trial results of auranofin, a novel antiparasitic agent","volume":"61","author":"Capparelli","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2022.02.010_b0190","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/femsre\/fux013","article-title":"Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance","volume":"41","author":"Navon-Venezia","year":"2017","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.drudis.2022.02.010_b0195","doi-asserted-by":"crossref","first-page":"22571","DOI":"10.1038\/srep22571","article-title":"Antibacterial activity and mechanism of action of auranofin against multi\u2013drug resistant bacterial pathogens","volume":"6","author":"Thangamani","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2022.02.010_b0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15027732.1986.12461442","article-title":"Long-term efficacy and safety of auranofin: a review of clinical experience","volume":"63","author":"Blodgett","year":"1986","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1016\/j.drudis.2022.02.010_b0205","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.4155\/fmc-2018-0544","article-title":"Auranofin is an effective agent against clinical isolates of Staphylococcus aureus","volume":"11","author":"Tharmalingam","year":"2019","journal-title":"Future Med Chem"},{"key":"10.1016\/j.drudis.2022.02.010_b0210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2013.07.036","article-title":"The thioredoxin antioxidant system","volume":"66","author":"Lu","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.drudis.2022.02.010_b0215","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1504022112","article-title":"Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis","volume":"112","author":"Harbut","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2022.02.010_b0220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4155\/fmc.15.182","article-title":"Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin","volume":"8","author":"Fuchs","year":"2016","journal-title":"Future Med Chem"},{"key":"10.1016\/j.drudis.2022.02.010_b0225","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40268-020-00306-3","article-title":"In vitro investigation of auranofin as a treatment for clostridium difficile infection","volume":"20","author":"Roder","year":"2020","journal-title":"Drugs R D"},{"key":"10.1016\/j.drudis.2022.02.010_b0230","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijantimicag.2018.09.018","article-title":"Antibacterial and antivirulence activities of auranofin against Clostridium difficile","volume":"53","author":"AbdelKhalek","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.drudis.2022.02.010_b0235","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/jac\/dkv163","article-title":"Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections","volume":"70","author":"Aguinagalde","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.drudis.2022.02.010_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.009","article-title":"Antivirulence activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies","volume":"55","author":"Abutaleb","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.drudis.2022.02.010_b0245","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1038\/s41598-018-26674-0","article-title":"Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci","volume":"8","author":"AbdelKhalek","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2022.02.010_b0250","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.3389\/fmicb.2019.02453","article-title":"Synergistic microbicidal effect of auranofin and antibiotics against planktonic and biofilm-encased S. aureus and E. faecalis","volume":"10","author":"She","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2022.02.010_b0255","doi-asserted-by":"crossref","first-page":"e00449","DOI":"10.1128\/AAC.00449-19","article-title":"Auranofin activity exposes thioredoxin reductase as a viable drug target in Mycobacterium abscessus","volume":"63","author":"Ruth","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2022.02.010_b0260","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/antibiotics10010026","article-title":"Auranofin has advantages over first-line drugs in the treatment of severe Streptococcus suis infections","volume":"10","author":"Lu","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.drudis.2022.02.010_b0265","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1038\/s41598-020-64352-2","article-title":"Auranofin rapidly eradicates methicillin-resistant Staphylococcus aureus (MRSA) in an infected pressure ulcer mouse model","volume":"10","author":"Mohammad","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2022.02.010_b0270","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jam.14443","article-title":"Antibiofilm efficacy of the gold compound auranofin on dual species biofilms of Staphylococcus aureus and Candida sp","volume":"128","author":"She","year":"2020","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.drudis.2022.02.010_b0275","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1128\/AAC.00377-16","article-title":"Screening a commercial library of pharmacologically active small molecules against Staphylococcus aureus biofilms","volume":"60","author":"Torres","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2022.02.010_b0280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijantimicag.2015.12.016","article-title":"Repurposing auranofin for the treatment of cutaneous staphylococcal infections","volume":"47","author":"Thangamani","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.drudis.2022.02.010_b0285","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10534-014-9743-6","article-title":"Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections","volume":"27","author":"Cassetta","year":"2014","journal-title":"Biometals"},{"key":"10.1016\/j.drudis.2022.02.010_b0290","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.24","article-title":"difficile infection: changing epidemiology and management paradigms","volume":"6","author":"Vindigni","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.drudis.2022.02.010_b0295","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fcimb.2019.00037","article-title":"Auranofin releasing antibacterial and antibiofilm polyurethane intravascular catheter coatings","volume":"9","author":"Liu","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.drudis.2022.02.010_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.538602","article-title":"Advances in biomaterials for the prevention and disruption of Candida biofilms","volume":"11","author":"Vera-Gonzalez","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2022.02.010_b0305","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/art.1780271121","article-title":"Neurotoxicity following a very high dose of oral gold (auranofin)","volume":"27","author":"Gambari","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.drudis.2022.02.010_b0310","first-page":"22","article-title":"Synthesis, antiinflammatory and antiarthritic properties of a new tiopronine gold derivative","volume":"128","author":"Coppi","year":"1989","journal-title":"Boll Chim Farm"},{"key":"10.1016\/j.drudis.2022.02.010_b0315","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3389\/fmicb.2018.01613","article-title":"Challenges of NTM drug development","volume":"9","author":"Falkinham","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2022.02.010_b0320","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1473-3099(13)70030-6","article-title":"Drug-resistant tuberculosis: time for visionary political leadership","volume":"13","author":"Abubakar","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.drudis.2022.02.010_b0325","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrmicro749","article-title":"Tuberculosis: a problem with persistence","volume":"1","author":"Stewart","year":"2003","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.drudis.2022.02.010_b0330","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nature09657","article-title":"The challenge of new drug discovery for tuberculosis","volume":"469","author":"Koul","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2022.02.010_b0335","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.676414","article-title":"Synergistic activity of colistin combined with auranofin against colistin-resistant Gram-negative bacteria","volume":"12","author":"Feng","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2022.02.010_b0340","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00203-019-01764-3","article-title":"Antibiofilm and antibacterial activities of repurposing auranofin against Bacteroides fragilis","volume":"202","author":"Jang","year":"2020","journal-title":"Arch Microbiol"},{"key":"10.1016\/j.drudis.2022.02.010_b0345","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fcimb.2018.00210","article-title":"Evaluating new compounds to treat Burkholderia pseudomallei infections","volume":"8","author":"Ross","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.drudis.2022.02.010_b0350","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jam.14312","article-title":"Repurposing auranofin to combat uropathogenic Escherichia coli biofilms","volume":"127","author":"Jang","year":"2019","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.drudis.2022.02.010_b0355","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1038\/s41467-020-18939-y","article-title":"Resensitizing carbapenem- and colistin\u2013resistant bacteria to antibiotics using auranofin","volume":"11","author":"Sun","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2022.02.010_b0360","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2016.123","article-title":"Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria","volume":"5","author":"Sun","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.drudis.2022.02.010_b0365","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1038\/s41598-020-62696-3","article-title":"Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae","volume":"10","author":"Elkashif","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2022.02.010_b0370","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/CMR.17.4.965-981.2004","article-title":"The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women","volume":"17","author":"Edwards","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.drudis.2022.02.010_b0375","doi-asserted-by":"crossref","first-page":"7751","DOI":"10.1021\/acs.jmedchem.9b00550","article-title":"Synthesis and structure-activity relationship study of antimicrobial auranofin against ESKAPE pathogens","volume":"62","author":"Wu","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2022.02.010_b0380","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/acsinfecdis.9b00251","article-title":"Sugar-modified analogs of auranofin are potent inhibitors of the gastric pathogen Helicobacter pylori","volume":"5","author":"Epstein","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.drudis.2022.02.010_b0385","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/cmdc.201800498","article-title":"Auranofin and its analogues show potent antimicrobial activity against multidrug-resistant pathogens: structure-activity relationships","volume":"13","author":"Marzo","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.drudis.2022.02.010_b0390","doi-asserted-by":"crossref","first-page":"14444","DOI":"10.1039\/D1DT02488D","article-title":"Medicinal Au(I) compounds targeting urease as prospective antimicrobial agents: unveiling the structural basis for enzyme inhibition","volume":"50","author":"Mazzei","year":"2021","journal-title":"Dalton Trans"},{"key":"10.1016\/j.drudis.2022.02.010_b0395","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10534-017-0046-6","article-title":"Lipophilic gold(I) complexes with 1,3,4-oxadiazol-2-thione or 1,3-thiazolidine-2-thione moieties: synthesis and their cytotoxic and antimicrobial activities","volume":"30","author":"de Almeida","year":"2017","journal-title":"Biometals"},{"key":"10.1016\/j.drudis.2022.02.010_b0400","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jinorgbio.2015.01.007","article-title":"(Aminophosphane)gold(I) and silver(I) complexes as antibacterial agents","volume":"146","author":"Ortego","year":"2015","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.drudis.2022.02.010_b0405","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.micpath.2018.08.002","article-title":"The antibacterial and anti-biofilm activity of gold-complexed sulfonamides against methicillin-resistant Staphylococcus aureus","volume":"123","author":"Mizdal","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.drudis.2022.02.010_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128158","article-title":"Silver(I) and gold(I) complexes with sulfasalazine: spectroscopic characterization, theoretical studies and antiproliferative activities over Gram-positive and Gram-negative bacterial strains","volume":"1214","author":"Fiori-Duarte","year":"2020","journal-title":"J Mol Struct"},{"key":"10.1016\/j.drudis.2022.02.010_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127879","article-title":"1,2,3-Triazole-gold(I)-triethylposphine derivatives active against resistant Gram-positive pathogens","volume":"40","author":"Michaut","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2022.02.010_b0420","doi-asserted-by":"crossref","first-page":"fnw148","DOI":"10.1093\/femsle\/fnw148","article-title":"Auranofin and N-heterocyclic carbene gold\u2013analogs are potent inhibitors of the bacteria Helicobacter pylori","volume":"363","author":"Owings","year":"2016","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.drudis.2022.02.010_b0425","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1039\/C7MD00269F","article-title":"Biscarbene gold(I) complexes: structure-activity-relationships regarding antibacterial effects, cytotoxicity, TrxR inhibition and cellular bioavailability","volume":"8","author":"Schmidt","year":"2017","journal-title":"Medchemcomm"},{"key":"10.1016\/j.drudis.2022.02.010_b0430","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/cmdc.201700257","article-title":"Steroid-Au(I) -NHC complexes: synthesis and antibacterial activity","volume":"12","author":"Velle","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.drudis.2022.02.010_b0435","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1002\/cmdc.202100381","article-title":"Gold(I) and gold(III) N-heterocyclic carbene complexes as antibacterial agents and inhibitors of bacterial thioredoxin reductase","volume":"16","author":"Bussing","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.drudis.2022.02.010_b0440","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bioorg.2018.08.006","article-title":"New bio-sensitive and biologically active single crystal of pyrimidine scaffold ligand and its gold and platinum complexes: DFT, antimicrobial, antioxidant, DNA interaction, molecular docking with DNA\/BSA and anticancer studies","volume":"81","author":"Sankarganesh","year":"2018","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.drudis.2022.02.010_b0445","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.2174\/092986712802430090","article-title":"Pyrazine functionalized Ag(I) and Au(I)-NHC complexes are potential antibacterial agents","volume":"19","author":"Roymahapatra","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.drudis.2022.02.010_b0450","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jinorgbio.2014.05.008","article-title":"Auranofin and related heterometallic gold(I)-thiolates as potent inhibitors of methicillin-resistant Staphylococcus aureus bacterial strains","volume":"138","author":"Hokai","year":"2014","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.drudis.2022.02.010_b0455","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1179\/joc.2006.18.6.648","article-title":"Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis","volume":"18","author":"Tascini","year":"2006","journal-title":"J Chemother"},{"key":"10.1016\/j.drudis.2022.02.010_b0460","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/cit253","article-title":"Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial","volume":"57","author":"Durante-Mangoni","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.drudis.2022.02.010_b0465","doi-asserted-by":"crossref","first-page":"2001374","DOI":"10.1002\/advs.202001374","article-title":"A macromolecule reversing antibiotic resistance phenotype and repurposing drugs as potent antibiotics","volume":"7","author":"Ding","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.drudis.2022.02.010_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2020.213492","article-title":"Advances in alkynyl gold complexes for use as potential anticancer agents","volume":"423","author":"Yang","year":"2020","journal-title":"Coordin Chem Rev"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644622000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644622000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:59:31Z","timestamp":1761224371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644622000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":94,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1359644622000691"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2022.02.010","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2022.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}